Literature DB >> 3884655

Modification of a direct enzyme-linked immunosorbent assay for the detection of immunoglobulin G and M antibodies to pneumococcal capsular polysaccharide.

J P Messina, P G Hickox, M L Lepow, B Pollara, R A Venezia.   

Abstract

In contrast to the usual indirect enzyme-linked immunosorbent assay (ELISA) method for detection of antibody responses, a modified direct ELISA technique was used to measure immunoglobulin G (IgG) and IgM responses to pneumococcal capsular types 1, 3, 9N, and 23F in humans. Individual capsular polysaccharides were covalently bound to poly-L-lysine before adsorption to the solid phase. The coupling reaction was enhanced by maintenance of a constant pH of 8.2 after the addition of all reactants. The evaluation of four diluents (phosphate-buffered saline [PBS]-Tween; PBS-Tween plus 10% fetal calf serum; PBS-Tween plus 10% bovine serum albumin; and PBS-Tween plus 20% normal goat serum) showed that the sensitivity and specificity of the assay was increased with normal goat serum (10-fold). Serum samples from 10 subjects immunized with polyvalent pneumococcal vaccine were tested by direct ELISA and by radioimmunoassay. At 4 weeks postimmunization, the ELISA method showed that IgG was the predominant antibody and that IgM responses were lower or had diminished. Isotype shifts during this period would have been undetected by the radioimmunoassay method. The changes in antibody response measured by ELISA were comparable to the radioimmunoassay results. The direct ELISA method for the detection of antipneumococcal capsular antibody has been found to be a sensitive and reproducible assay for the detection of IgG and IgM antibodies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884655      PMCID: PMC271671          DOI: 10.1128/jcm.21.3.390-394.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Prevention of pneumococcal pneumonia by vaccination.

Authors:  R Austrian; R M Douglas; G Schiffman; A M Coetzee; H J Koornhof; S Hayden-Smith; R D Reid
Journal:  Trans Assoc Am Physicians       Date:  1976

2.  Protective efficacy of pneumococcal polysaccharide vaccines.

Authors:  P Smit; D Oberholzer; S Hayden-Smith; H J Koornhof; M R Hilleman
Journal:  JAMA       Date:  1977-12-12       Impact factor: 56.272

3.  The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity.

Authors:  J E Butler; T L Feldbush; P L McGivern; N Stewart
Journal:  Immunochemistry       Date:  1978-02

4.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

Review 5.  Pneumococcal vaccine: a tool for the evaluation of the B-cell function of the immune system.

Authors:  G Schiffman
Journal:  Proc Soc Exp Biol Med       Date:  1983-12

6.  Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay.

Authors:  D J Barrett; A J Ammann; S Stenmark; D W Wara
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

8.  Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay.

Authors:  F K Pedersen; J Henrichsen
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

9.  Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination.

Authors:  A J Ammann; R J Pelger
Journal:  Appl Microbiol       Date:  1972-11

10.  A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques.

Authors:  G Schiffman; R M Douglas; M J Bonner; M Robbins; R Austrian
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

View more
  7 in total

1.  Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides.

Authors:  Raymond E Biagini; Sonela A Schlottmann; Deborah L Sammons; Jerome P Smith; John C Snawder; Cynthia A F Striley; Barbara A MacKenzie; David N Weissman
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

2.  Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Authors:  Saeyoung Park; Moon H Nahm
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Measurement of pneumococcal capsular polysaccharide serotype-specific immunoglobulin G in human serum, a method for assigning weight-based units to proposed reference sera.

Authors:  K M Rudolph; A J Parkinson
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

4.  Detection of immunoglobulin G to Pasteurella haemolytica capsular polysaccharide by enzyme-linked immunosorbent assay.

Authors:  E L Townsend; S K Maheswaran; J R Leininger; T R Ames
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

5.  Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C.

Authors:  O A Akinwolere; D S Kumararatne; R Bartlett; D M Goodall; D Catty
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

6.  Antibodies to pneumococcal polysaccharides in pneumonia and response to pneumococcal vaccination in young children in Papua New Guinea.

Authors:  C S Witt; W Pomat; D Lehmann; M P Alpers
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

7.  Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.

Authors:  Sanjay K Singh; Donald N Ngwa; Alok Agrawal
Journal:  Front Immunol       Date:  2020-08-13       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.